Prudent Man Advisors, LLC Bristol Myers Squibb CO Transaction History
Prudent Man Advisors, LLC
- $306 Million
- Q2 2025
A detailed history of Prudent Man Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 12,303 shares of BMY stock, worth $562,616. This represents 0.19% of its overall portfolio holdings.
Number of Shares
12,303
Previous 12,585
2.24%
Holding current value
$562,616
Previous $767,000
25.81%
% of portfolio
0.19%
Previous 0.29%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.91 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.26 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.94 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.33 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.24 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...